PK BIOTECH ApS

Description of key activities of the company The group is engaged in producing ingredients for the pharmaceutical, veterinary and cosmetics industries. The group manufactures and adapts special ingredients in cooperation with the customers.s, as well as the financing and ownership of shares and equity interests. Material uncertainty about going concern The ability of PK Biotech ApS and PK Biotech Group to continue as a going concern is dependent on continued financial support from its parent company, Chemoswed Holding AB. The Magle Chemoswed Group's external financing consists primarily of corporate bonds issued by Magle Chemoswed Holding AB, as well as other financing arrangements provided at Group level. PK Biotech ApS and PK Biotech Group has no external financing of its own and is funded through financial resources provided within the Magle Chemoswed Group.Accordingly, the ability of PK Biotech ApS and PK Biotech Group to continue as a going concern is dependent on the ability of Magle Chemoswed Holding AB to maintain existing financing arrangements, secure additional financing and, where necessary, implement capital measures. For further description reference is made to note 1 "Material uncertainties about going concern".